Exact Mass: 275.0324

Exact Mass Matches: 275.0324

Found 49 metabolites which its exact mass value is equals to given mass value 275.0324, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Phosphophosphinate

Phosphophosphinate

C6H15NO7P2 (275.0324)


   

D-glucosaminic acid 6-phosphate

D-Glucosaminate-6-phosphate; 2-Amino-2-deoxy-D-gluconate 6-phosphate

C6H14NO9P (275.0406)


   

N-(2-formyl-3-chlorophenyl)anthranilic acid

2-[(3-chloro-2-formylphenyl)amino]benzoic acid

C14H10ClNO3 (275.0349)


N-(2-formyl-3-chlorophenyl)anthranilic acid belongs to the family of Aminobenzoic Acid Derivatives. These are organic compounds containing a benzoic acid moiety with an amine group attached to the benzene ring.

   

Lorcaserin sulfamate

8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-3-sulfonic acid

C11H14ClNO3S (275.0383)


Lorcaserin sulfamate is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)

   

Meticrane

6-Methyl-1,1-dioxo-3,4-dihydro-2H-1λ⁶-benzothiopyran-7-sulphonamide

C10H13NO4S2 (275.0286)


C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic

   

(5R)-3-Ethylsulfanyl-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R)-3-Ethylsulphanyl-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C10H13NO4S2 (275.0286)


   
   
   
   

7,8-Dihydroxy-3-(2-methyl-thiazol-4-yl)-chromen-4-one

"NCGC00160278-01!7,8-Dihydroxy-3-(2-methyl-thiazol-4-yl)-chromen-4-one"

C13H9NO4S (275.0252)


   

Sulfamethoxazole sodium

Sulfamethoxazole sodium

C10H10N3NaO3S (275.0341)


   

(2-Chloro-4-nitrophenyl)(2-methylphenyl)methanone

(2-Chloro-4-nitrophenyl)(2-methylphenyl)methanone

C14H10ClNO3 (275.0349)


   

2-[(4-chlorobenzoyl)amino]benzoic acid

2-[(4-chlorobenzoyl)amino]benzoic acid

C14H10ClNO3 (275.0349)


   

Ethyl2-amino-2-[2-(2,4-dichlorophenyl)hydrazono]-acetate

Ethyl2-amino-2-[2-(2,4-dichlorophenyl)hydrazono]-acetate

C10H11Cl2N3O2 (275.0228)


   

Benzoic acid,2-[[(3-chlorophenyl)amino]carbonyl]-

Benzoic acid,2-[[(3-chlorophenyl)amino]carbonyl]-

C14H10ClNO3 (275.0349)


   

Actinoquinol sodium

Actinoquinol sodium

C11H10NNaO4S (275.0228)


   

iron(iii) ionophore i

iron(iii) ionophore i

C14H10ClNO3 (275.0349)


   

2-benzamido-5-chlorobenzoic acid

2-benzamido-5-chlorobenzoic acid

C14H10ClNO3 (275.0349)


   

N-(4-Bromophenyl)-N-(1-phenylethyl)amine

N-(4-Bromophenyl)-N-(1-phenylethyl)amine

C14H14BrN (275.031)


   

3-HYDROXYMETHYL-6-(2-NITROPHENYL)IMIDAZO[2,1-B]THIAZOLE

3-HYDROXYMETHYL-6-(2-NITROPHENYL)IMIDAZO[2,1-B]THIAZOLE

C12H9N3O3S (275.0365)


   

2-(3-Amino-4-chloro-benzoyl)benzoic acid

2-(3-Amino-4-chloro-benzoyl)benzoic acid

C14H10ClNO3 (275.0349)


   

6-Chloro-N-benzoylanthranilic acid

6-Chloro-N-benzoylanthranilic acid

C14H10ClNO3 (275.0349)


   

4-[(2-chlorobenzoyl)amino]benzoic acid

4-[(2-chlorobenzoyl)amino]benzoic acid

C14H10ClNO3 (275.0349)


   

6-AMINO-5-BROMO-1-ISOBUTYL-3-METHYL-1H-PYRIMIDINE-2,4-DIONE

6-AMINO-5-BROMO-1-ISOBUTYL-3-METHYL-1H-PYRIMIDINE-2,4-DIONE

C9H14BrN3O2 (275.0269)


   

2-(2-CHLORO-ACETYLAMINO)-4,5-DIMETHYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

2-(2-CHLORO-ACETYLAMINO)-4,5-DIMETHYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C11H14ClNO3S (275.0383)


   

1-(4-CHLORO-2-FLUOROPHENYL)-PIPERAZINE

1-(4-CHLORO-2-FLUOROPHENYL)-PIPERAZINE

C14H10ClNO3 (275.0349)


   

2-(5-nitrothiophen-2-yl)-2,3-dihydro-1H-quinazolin-4-one

2-(5-nitrothiophen-2-yl)-2,3-dihydro-1H-quinazolin-4-one

C12H9N3O3S (275.0365)


   
   

methyl 3-(pyrrolidin-1-ylsulfonyl)thiophene-2-carboxylate

methyl 3-(pyrrolidin-1-ylsulfonyl)thiophene-2-carboxylate

C10H13NO4S2 (275.0286)


   

(4-CHLORO-3-NITROPHENYL)(P-TOLYL)METHANONE

(4-CHLORO-3-NITROPHENYL)(P-TOLYL)METHANONE

C14H10ClNO3 (275.0349)


   

4-chloro-6-(4-methylphenyl)-2-(methylthio)pyrimidine-5-carbonitrile

4-chloro-6-(4-methylphenyl)-2-(methylthio)pyrimidine-5-carbonitrile

C13H10ClN3S (275.0284)


   

2-Chloro-1-(4-nitro-[1,1-biphenyl]-4-yl)ethanone

2-Chloro-1-(4-nitro-[1,1-biphenyl]-4-yl)ethanone

C14H10ClNO3 (275.0349)


   

Benzoicacid, 2-[[(2-chlorophenyl)amino]carbonyl]-

Benzoicacid, 2-[[(2-chlorophenyl)amino]carbonyl]-

C14H10ClNO3 (275.0349)


   

4-(CHLOROMETHYL)-5-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)OXAZOLE

4-(CHLOROMETHYL)-5-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)OXAZOLE

C12H9ClF3NO (275.0325)


   

3-NITRO-4-(PHENYLTHIO)BENZOIC ACID

3-NITRO-4-(PHENYLTHIO)BENZOIC ACID

C13H9NO4S (275.0252)


   

3-piperidin-1-ylsulfonylthiophene-2-carboxylic acid

3-piperidin-1-ylsulfonylthiophene-2-carboxylic acid

C10H13NO4S2 (275.0286)


   

2-(2-bromophenyl)-N,N-dimethylaniline

2-(2-bromophenyl)-N,N-dimethylaniline

C14H14BrN (275.031)


   

BENZYL-(3-BROMOBENZYL)AMINE

BENZYL-(3-BROMOBENZYL)AMINE

C14H14BrN (275.031)


   

2-[(3-chlorophenyl)methylsulfanyl]-3H-imidazo[4,5-c]pyridine

2-[(3-chlorophenyl)methylsulfanyl]-3H-imidazo[4,5-c]pyridine

C13H10ClN3S (275.0284)


   

4-Amino-N-[(2-Sulfanylethyl)carbamoyl]benzenesulfonamide

4-Amino-N-[(2-Sulfanylethyl)carbamoyl]benzenesulfonamide

C9H13N3O3S2 (275.0398)


   

Ethyl (1E)-2-phenyl-N-(sulfooxy)ethanimidothioate

Ethyl (1E)-2-phenyl-N-(sulfooxy)ethanimidothioate

C10H13NO4S2 (275.0286)


   

Meticrane

Meticrane

C10H13NO4S2 (275.0286)


C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic

   

Lorcaserin sulfamate

8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-3-sulfonic acid

C11H14ClNO3S (275.0383)


Lorcaserin sulfamate is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)

   

3-Ethylsulfanyl-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

3-Ethylsulfanyl-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C10H13NO4S2 (275.0286)


   

acetic acid [3-oxo-2-(trifluoromethyl)-4H-1,4-benzoxazin-2-yl] ester

acetic acid [3-oxo-2-(trifluoromethyl)-4H-1,4-benzoxazin-2-yl] ester

C11H8F3NO4 (275.0405)


   

2-[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]-1-(1H-pyrrol-2-yl)ethanone

2-[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]-1-(1H-pyrrol-2-yl)ethanone

C12H9N3O3S (275.0365)


   

Sodium;(4-aminophenyl)sulfonyl-(4-methyl-1,2-oxazol-3-yl)azanide

Sodium;(4-aminophenyl)sulfonyl-(4-methyl-1,2-oxazol-3-yl)azanide

C10H10N3NaO3S (275.0341)


   

Cambridge id 6875303

Cambridge id 6875303

C13H9NO4S (275.0252)


   

N-(2-formyl-3-chlorophenyl)anthranilic acid

N-(2-formyl-3-chlorophenyl)anthranilic acid

C14H10ClNO3 (275.0349)